4YHO | Reversal Agent for Dabigatran | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Schiele, F., Nar, H. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.82 | ||||||||||||
ligand | 4CC | enzyme |
| ||||||||||||
Primary reference | Structure-guided residence time optimization of a dabigatran reversal agent., Schiele F, van Ryn J, Litzenburger T, Ritter M, Seeliger D, Nar H, MAbs. 2015 Jun 5:0. PMID:26047352 |
Data retrieval |
View 4YHO in 3D |
Visual 3D analysis of 4YHO |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4YHO |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |